Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

Clinical trial NCT00485966 · WITHDRAWN

Trial details

NCT number: NCT00485966
Sponsor: Cylene Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia

Start date: 2007-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.